Weill Cornell Medicine

Search Results

Showing results 9581 - 9590 for 2023

Outcome of deferred initial therapy in mantle-cell lymphoma. | Pathology & Laboratory Medicine

...2016 Resident Research Day 2015 Resident Research Day 2014 Pathology Trainee Research Day - May 10, 2023...

https://pathology.weill.cornell.edu/research/publications/outcome-deferred-initial-therapy-mantle-cell-lymphoma

Mutually exclusive cyclin-dependent kinase 4/cyclin D1 and cyclin-dependent kinase 6/cyclin D2 pairing inactivates retinoblastoma protein and promotes cell cycle dysregulation in multiple myeloma. | Pathology & Laboratory Medicine

...2016 Resident Research Day 2015 Resident Research Day 2014 Pathology Trainee Research Day - May 10, 2023...

https://pathology.weill.cornell.edu/research/publications/mutually-exclusive-cyclin-dependent-kinase-4cyclin-d1-and-cyclin-dependent

CDK2 phosphorylation of Smad2 disrupts TGF-beta transcriptional regulation in resistant primary bone marrow myeloma cells. | Pathology & Laboratory Medicine

...2016 Resident Research Day 2015 Resident Research Day 2014 Pathology Trainee Research Day - May 10, 2023...

https://pathology.weill.cornell.edu/research/publications/cdk2-phosphorylation-smad2-disrupts-tgf-beta-transcriptional-regulation

A novel orally active small molecule potently induces G1 arrest in primary myeloma cells and prevents tumor growth by specific inhibition of cyclin-dependent kinase 4/6. | Pathology & Laboratory Medicine

...2016 Resident Research Day 2015 Resident Research Day 2014 Pathology Trainee Research Day - May 10, 2023...

https://pathology.weill.cornell.edu/research/publications/novel-orally-active-small-molecule-potently-induces-g1-arrest-primary-myeloma

A novel therapeutic combination using PD 0332991 and bortezomib: study in the 5T33MM myeloma model. | Pathology & Laboratory Medicine

...2016 Resident Research Day 2015 Resident Research Day 2014 Pathology Trainee Research Day - May 10, 2023...

https://pathology.weill.cornell.edu/research/publications/novel-therapeutic-combination-using-pd-0332991-and-bortezomib-study-5t33mm

Phase 1/2 study of cyclin-dependent kinase (CDK)4/6 inhibitor palbociclib (PD-0332991) with bortezomib and dexamethasone in relapsed/refractory multiple myeloma. | Pathology & Laboratory Medicine

...2016 Resident Research Day 2015 Resident Research Day 2014 Pathology Trainee Research Day - May 10, 2023...

https://pathology.weill.cornell.edu/research/publications/phase-12-study-cyclin-dependent-kinase-cdk46-inhibitor-palbociclib-pd-0332991

A New Bayesian Lasso | Mallick Lab

...Software Resources Home Publications A New Bayesian Lasso Submitted by yil4023 on September 5, 2023...

https://mallicklab.weill.cornell.edu/publications/new-bayesian-lasso

Bayesian Bridge Regression | Mallick Lab

...Resources Home Publications Bayesian Bridge Regression Submitted by yil4023 on September 5, 2023...

https://mallicklab.weill.cornell.edu/publications/bayesian-bridge-regression

Reducing Risk of Opioid Addiction While Alleviating Pain | Government & Community Affairs

...In 2023, opioid abuse or overuse was responsible for more than 80,000 deaths, fueling a national crisis...

https://gca.weill.cornell.edu/news/reducing-risk-opioid-addiction-while-alleviating-pain

Congratulations to our Director Dr. James Curtis, PhD and Colleagues on Publishing their New Research on Low-Cost Manometer for Objective Assessments of Respiratory Muscle Strength | Aerodigestive Innovations Research Lab (AIR)

...Share to Facebook Share to Twitter Share to LinkedIn Share on Email December 7, 2023...

https://airlab.weill.cornell.edu/news/congratulations-our-director-dr-james-curtis-phd-and-colleagues-publishing-their-new-research-3

Showing results 9581 - 9590 for 2023